Pennsylvania, Editors, Raphael Rubin, M.D., Professor of Pathology, David S. Strayer, M.D., Ph.D., Professor of Pathology, Department of Pathology and Cell Biology, Jefferson Medical College of Thomas Jefferson University Philadelphia, Pennsylvania ; Founder and Consulting Editor, Emanuel Rubin, M.D., Gonzalo Aponte Distinguished Professor of Pathology, Chairman Emeritus of the Department of Pathology and Cell Biology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, (2011). Rubin's pathology : clinicopathologic foundations of medicine (Sixth ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 154. ISBN978-1-60547-968-2. https://books.google.com/books?id=wb2TzY9AgJ0C&pg=PA154
“Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS”. J. Gen. Virol.84 (7): 1649–1661. (2003). doi:10.1099/vir.0.19110-0. PMID12810858.
Smith, Johanna A.; Daniel, René (Division of Infectious Diseases, Center for Human Virology, Thomas Jefferson University, Philadelphia) (2006). “Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses”. ACS Chem Biol1 (4): 217–26. doi:10.1021/cb600131q. PMID17163676.
“Hybrid Spreading Mechanisms and T Cell Activation Shape the Dynamics of HIV-1 Infection”. PLOS Computational Biology11 (4): e1004179. (2015). doi:10.1371/journal.pcbi.1004179. PMID25837979.
“HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse”. Journal of Experimental Medicine199 (2): 283–293. (2004). doi:10.1084/jem.20030648. PMID14734528.
“Avoiding the void: cell-to-cell spread of human viruses”. Nature Reviews Microbiology6 (11): 815–826. (2008). doi:10.1038/nrmicro1972. PMID18923409.
“Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy”. Nature477 (7362): 95–98. (2011). doi:10.1038/nature10347. PMID21849975.
Gilbert, PB et al. (February 28, 2003). “Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal”. Statistics in Medicine22 (4): 573–593. doi:10.1002/sim.1342. PMID12590415.
Reeves, J. D.; Doms, R. W (2002). “Human Immunodeficiency Virus Type 2”. J. Gen. Virol.83 (Pt 6): 1253–65. doi:10.1099/vir.0.18253-0. PMID12029140.
“HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?”. AIDS16 (4): 597–632. (2002). doi:10.1097/00002030-200203080-00011. PMID11873003.
Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR 3rd, Moore RD, Freedberg KA. (2006). “The lifetime cost of current HIV care in the United States”. Med Care44 (11): 990–997. doi:10.1097/01.mlr.0000228021.89490.2a. PMID17063130.
van Sighem, AI; Gras, LA; Reiss, P; Brinkman, K; de Wolf, F; ATHENA national observational cohort, study (June 19, 2010). “Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals”. AIDS (London, England)24 (10): 1527–35. doi:10.1097/QAD.0b013e32833a3946. PMID20467289.
Cheung, MC; Pantanowitz, L; Dezube, BJ (Jun–Jul 2005). “AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy”. The oncologist10 (6): 412–26. doi:10.1634/theoncologist.10-6-412. PMID15967835.
“The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy”. AIDS17 (Suppl 4): S51–S60. (2003). doi:10.1097/00002030-200317004-00006. PMID15080180.
Lawn SD (2004). “AIDS in Africa: the impact of co-infections on the pathogenesis of HIV-1 infection”. J. Infect. Dis.48 (1): 1–12. doi:10.1016/j.jinf.2003.09.001. PMID14667787.
Campbell GR; Pasquier E; Watkins J et al. (2004). “The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis”. J. Biol. Chem.279 (46): 48197–48204. doi:10.1074/jbc.M406195200. PMID15331610.
“The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells”. J. Biol. Chem.280 (46): 38376–39382. (2005). doi:10.1074/jbc.M506630200. PMID16155003.
Brown, T.; Qaqish, R. (2006). “Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review”. AIDS (London, England)20 (17): 2165–2174. doi:10.1097/QAD.0b013e32801022eb. PMID17086056.
Nicholas, P.K.; Kemppainen, J.K.; Canaval, G.E. et al. (February 2007). “Symptom management and self-care for peripheral neuropathy in HIV/AIDS”. AIDS Care19 (2): 179–89. doi:10.1080/09540120600971083. PMID17364396.
“Therapy insight: AIDS-related malignancies – the influence of antiviral therapy on pathogenesis and management”. Nat. Clin. Pract. Oncol.2 (8): 406–415. (2005). doi:10.1038/ncponc0253. PMID16130937.
Post, F. .; Holt, S. . (2009). “Recent developments in HIV and the kidney”. Current opinion in infectious diseases22 (1): 43–48. doi:10.1097/QCO.0b013e328320ffec. PMID19106702.
“Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS”. J. Gen. Virol.84 (7): 1649–1661. (2003). doi:10.1099/vir.0.19110-0. PMID12810858.
Smith, Johanna A.; Daniel, René (Division of Infectious Diseases, Center for Human Virology, Thomas Jefferson University, Philadelphia) (2006). “Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses”. ACS Chem Biol1 (4): 217–26. doi:10.1021/cb600131q. PMID17163676.
“Hybrid Spreading Mechanisms and T Cell Activation Shape the Dynamics of HIV-1 Infection”. PLOS Computational Biology11 (4): e1004179. (2015). doi:10.1371/journal.pcbi.1004179. PMID25837979.
“HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse”. Journal of Experimental Medicine199 (2): 283–293. (2004). doi:10.1084/jem.20030648. PMID14734528.
“Avoiding the void: cell-to-cell spread of human viruses”. Nature Reviews Microbiology6 (11): 815–826. (2008). doi:10.1038/nrmicro1972. PMID18923409.
“Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy”. Nature477 (7362): 95–98. (2011). doi:10.1038/nature10347. PMID21849975.
Gilbert, PB et al. (February 28, 2003). “Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal”. Statistics in Medicine22 (4): 573–593. doi:10.1002/sim.1342. PMID12590415.
Reeves, J. D.; Doms, R. W (2002). “Human Immunodeficiency Virus Type 2”. J. Gen. Virol.83 (Pt 6): 1253–65. doi:10.1099/vir.0.18253-0. PMID12029140.
“HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?”. AIDS16 (4): 597–632. (2002). doi:10.1097/00002030-200203080-00011. PMID11873003.
Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR 3rd, Moore RD, Freedberg KA. (2006). “The lifetime cost of current HIV care in the United States”. Med Care44 (11): 990–997. doi:10.1097/01.mlr.0000228021.89490.2a. PMID17063130.
van Sighem, AI; Gras, LA; Reiss, P; Brinkman, K; de Wolf, F; ATHENA national observational cohort, study (June 19, 2010). “Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals”. AIDS (London, England)24 (10): 1527–35. doi:10.1097/QAD.0b013e32833a3946. PMID20467289.
Cheung, MC; Pantanowitz, L; Dezube, BJ (Jun–Jul 2005). “AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy”. The oncologist10 (6): 412–26. doi:10.1634/theoncologist.10-6-412. PMID15967835.
“The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy”. AIDS17 (Suppl 4): S51–S60. (2003). doi:10.1097/00002030-200317004-00006. PMID15080180.
Lawn SD (2004). “AIDS in Africa: the impact of co-infections on the pathogenesis of HIV-1 infection”. J. Infect. Dis.48 (1): 1–12. doi:10.1016/j.jinf.2003.09.001. PMID14667787.
Campbell GR; Pasquier E; Watkins J et al. (2004). “The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis”. J. Biol. Chem.279 (46): 48197–48204. doi:10.1074/jbc.M406195200. PMID15331610.
“The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells”. J. Biol. Chem.280 (46): 38376–39382. (2005). doi:10.1074/jbc.M506630200. PMID16155003.
Brown, T.; Qaqish, R. (2006). “Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review”. AIDS (London, England)20 (17): 2165–2174. doi:10.1097/QAD.0b013e32801022eb. PMID17086056.
Nicholas, P.K.; Kemppainen, J.K.; Canaval, G.E. et al. (February 2007). “Symptom management and self-care for peripheral neuropathy in HIV/AIDS”. AIDS Care19 (2): 179–89. doi:10.1080/09540120600971083. PMID17364396.
“Therapy insight: AIDS-related malignancies – the influence of antiviral therapy on pathogenesis and management”. Nat. Clin. Pract. Oncol.2 (8): 406–415. (2005). doi:10.1038/ncponc0253. PMID16130937.
Post, F. .; Holt, S. . (2009). “Recent developments in HIV and the kidney”. Current opinion in infectious diseases22 (1): 43–48. doi:10.1097/QCO.0b013e328320ffec. PMID19106702.